Observational study focuses on how cancer treatments were associated with two important clinical measures and risk of death in nearly 200 patients with HIV and cancer

New method  means doctors can eliminate precancerous cysts and potentially save lives 

The phase II trial found that over 80 percent of men with prostate cancer whose tumors had mutations in the BRCA genes responded well to treatment with the targeted drug olaparib

A new study suggests that the STAT test order should rest in peace

Recent study finds that one in 20 men with end-stage prostate cancer responded to the immunotherapy pembrolizumab 

Examining the symptoms, pathogenesis, diagnosis, treatment, and new research related to endometriosis. 

As drug test adulteration becomes more sophisticated, so do detection methods

Point-of-care technologies hold tremendous potential to improve health care delivery

Going automated can be a lengthy process, but patients ultimately benefit

Technical solutions to the unique challenges of rare cell detection